Skip to main content

Notice

The new RDA web platform is still being rolled out. Existing RDA members PLEASE REACTIVATE YOUR ACCOUNT using this link: https://rda-login.wicketcloud.com/users/confirmation. Please report bugs, broken links and provide your feedback using the UserSnap tool on the bottom right corner of each page. Stay updated about the web site milestones at https://www.rd-alliance.org/rda-web-platform-upcoming-features-and-functionalities/.

Last Clinical Subgroup call on use cases and future steps

  • Creator
    Discussion
  • #103910

    Dawei Lin
    Member

    Dear all,
    We will have our last call for the subgroup, but it does not mean our work stops. We will discuss a few ideas to follow up on our recommendations and guidelines.
    1. What are the use cases for our recommendations and guidelines
    2. What do we want to leverage our writing so far? To develop it into a white paper or a publication?
    We welcome you to join us 13.00 UTC on June 17, 2020 at https://global.gotomeeting.com or use the direct URL https://global.gotomeeting.com/join/903049133
    Co-Moderators: Sergio Bonini (***@***.***), Andrea Jackson-Dipina (***@***.***), Dawei Lin (***@***.***), Christian Ohmann ( ***@***.***-duesseldorf.de )
    Co-Chair Liaison: Anne Cambon-Thomsen (***@***.***-tlse3.fr)

  • Author
    Replies
  • #129742

    Dear Dawei,
    Dear all,
    What is the time frame for the meeting?
    Actually, I have 3 (!!) other meetings (ISO meetings) in parallel already, so I only could join in for short time and only later in this meeting.
    Thanks and best regards,
    Martin
    ——————————————
    Martin Golebiewski
    HITS gGmbH
    Schloss-Wolfsbrunnenweg 35
    69118 Heidelberg
    Germany
    phone +49 6221 533 281
    fax +49 6221 533 298
    email ***@***.***-its.org
    http://www.h-its.org
    _________________________________________________
    Amtsgericht Mannheim / HRB 337446
    Managing Director: Dr. Gesa Schönberger
    Scientific Director: PD Wolfgang Müller
    Von: im Auftrag von daweilin via RDA-COVID19-Clinical
    Antworten an: “***@***.***
    Datum: Dienstag, 16. Juni 2020 um 21:40
    An: “***@***.***-groups.org
    Cc: “Jackson-Dipina, Andrea (NIH/OD) [E]” , Sergio Bonini , Anne Cambon-Thomsen , “***@***.***-duesseldorf.de
    Betreff: [rda-covid19-clinical] Last Clinical Subgroup call on use cases and future steps
    Dear all,
    We will have our last call for the subgroup, but it does not mean our work stops. We will discuss a few ideas to follow up on our recommendations and guidelines.
    1. What are the use cases for our recommendations and guidelines
    2. What do we want to leverage our writing so far? To develop it into a white paper or a publication?
    We welcome you to join us 13.00 UTC on June 17, 2020 at https://global.gotomeeting.com or use the direct URL https://global.gotomeeting.com/join/903049133
    Co-Moderators: Sergio Bonini (***@***.***), Andrea Jackson-Dipina (***@***.***), Dawei Lin (***@***.***), Christian Ohmann ( ***@***.***-duesseldorf.de )
    Co-Chair Liaison: Anne Cambon-Thomsen (***@***.***-tlse3.fr)

  • #129741

    Dawei Lin
    Member

    Hi Martin,
    Thank you for letting us know. Today meeting is open and depends on the use cases. So we may end early. We can always catch up if you can not join us.
    Dawei
    From: “Golebiewski, Martin”
    Date: Wednesday, June 17, 2020 at 8:38 AM
    To: “Lin, Dawei (NIH/NIAID) [E]” , “***@***.***-groups.org
    Cc: “Jackson-Dipina, Andrea (NIH/OD) [E]” , Sergio Bonini , Anne Cambon-Thomsen , “***@***.***-duesseldorf.de
    Subject: Re: [rda-covid19-clinical] Last Clinical Subgroup call on use cases and future steps
    Dear Dawei,
    Dear all,
    What is the time frame for the meeting?
    Actually, I have 3 (!!) other meetings (ISO meetings) in parallel already, so I only could join in for short time and only later in this meeting.
    Thanks and best regards,
    Martin
    ——————————————
    Martin Golebiewski
    HITS gGmbH
    Schloss-Wolfsbrunnenweg 35
    69118 Heidelberg
    Germany
    phone +49 6221 533 281
    fax +49 6221 533 298
    email ***@***.***-its.org
    http://www.h-its.org
    _________________________________________________
    Amtsgericht Mannheim / HRB 337446
    Managing Director: Dr. Gesa Schönberger
    Scientific Director: PD Wolfgang Müller
    Von: im Auftrag von daweilin via RDA-COVID19-Clinical
    Antworten an: “***@***.***
    Datum: Dienstag, 16. Juni 2020 um 21:40
    An: “***@***.***-groups.org
    Cc: “Jackson-Dipina, Andrea (NIH/OD) [E]” , Sergio Bonini , Anne Cambon-Thomsen , “***@***.***-duesseldorf.de
    Betreff: [rda-covid19-clinical] Last Clinical Subgroup call on use cases and future steps
    Dear all,
    We will have our last call for the subgroup, but it does not mean our work stops. We will discuss a few ideas to follow up on our recommendations and guidelines.
    1. What are the use cases for our recommendations and guidelines
    2. What do we want to leverage our writing so far? To develop it into a white paper or a publication?
    We welcome you to join us 13.00 UTC on June 17, 2020 at https://global.gotomeeting.com or use the direct URL https://global.gotomeeting.com/join/903049133
    Co-Moderators: Sergio Bonini (***@***.***), Andrea Jackson-Dipina (***@***.***), Dawei Lin (***@***.***), Christian Ohmann ( ***@***.***-duesseldorf.de )
    Co-Chair Liaison: Anne Cambon-Thomsen (***@***.***-tlse3.fr)

Log in to reply.